Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Transcatheter Tricuspid Valve Interventions in the TAVR Population
Author(s): Molly Silkowski , Payton Kendsersky , Nicholas Amoroso Added: 1 year ago

Heart Failure

Intervention
TCT 24: The TRISCEND II Trial
Author(s): Susheel Kodali Added: 1 year ago
TCT Conference 2024 - Safety and efficacy outcomes of transcatheter tricuspid valve replacement (TTVR) compared to optimal medical therapy for patients with severe tricuspid regurgitation (TR).Dr Susheel Kodali (Columbia University Medical Center, New York, US) joins us onsite at TCT Conference to discuss the findings from the TRISCEND II Trial (NCT04482062; Edwards Lifesciences).TRISCEND II is a… View more

Intervention
ESC 25: TRISCEND II Trial: TTVR Outcomes by Baseline TR Severity
Author(s): Philipp Lurz Added: 4 months ago
ESC Congress 2025 - New findings from a post-hoc analysis of TRISCEND II show that TTVR can reduce the rate of heart failure hospitalisations, particularly in the case of patients who present with massive or torrential TR - irrespective of baseline TR severity.Prof Philipp Lurz (University Mainz, DE) discusses new findings from the TRISCEND II trial, examining how baseline tricuspid regurgitation… View more

Intervention
EuroPCR 25: The TRICURE EU Study
Author(s): Julien Dreyfus Added: 7 months ago
EuroPCR 25 - First-in-human outcomes from the TRiCares Topaz Tricuspid Valve Replacement System in patents with tricuspid regurgitation (TR) show positive performance results and improved safety.We are joined by Dr Julien Dreyfus (Centre Cardiologique du Nord, Saint-Denis, FR) to discuss outcomes from the first-in-human, pivotal, multi-centre TRICURE EU study (NCT06581471; TRiCares) investigating… View more

Intervention
DELINEATE-Regurgitation: AI Accurately Classifies Valvular Regurgitation and Predicts MR Progression
Added: 5 months ago Source:  Radcliffe Cardiology
The classification and risk stratification of aortic, mitral, and tricuspid regurgitation present significant clinical challenges, with diagnosis often subject to interobserver variability. The DELINEATE-Regurgitation study investigated a novel artificial intelligence (AI) system designed to provide accurate, reproducible echocardiographic assessment of valvular regurgitation and to stratify the… View more

Digital Health

Guidelines & Statements
Navigating Mitral and Tricuspid Valve Disease: Diagnosis, Quality of Life, and Patient-Centered Care
Author(s): , Start date: Aug 06, 2025
Mitral and tricuspid regurgitation remain under-recognised and undertreated despite their significant impact on symptoms, quality of life, and outcomes. In this expert-led webinar, Suzanne V. Arnold, MD (Saint Luke’s Health System, Kansas City, US) offers practical guidance on recognising heart valve disease early, navigating referral pathways, and integrating patient-centred data into everyday… View more

Intervention
EuroPCR 25: TRILUMINATE Pivotal 2Y Outcomes
Author(s): Gagan Singh Added: 7 months ago
EuroPCR25 - Two-year data confirms sustained benefits of TriClip for severe tricuspid regurgitation.We are joined by Dr Gagan Singh (UC Davis Medical Center, Sacramento, CA, US) to discuss key findings from the TRILUMINATE pivotal trial. This randomised controlled trial compared the TriClip device against medical therapy in symptomatic patients with severe tricuspid regurgitation (TR) who are at… View more

Intervention
EuroPCR 25: The FATE Registry
Author(s): Fedrico de Marco Added: 7 months ago
EuroPCR 2025 - Outcomes from the FATE Registry show coapttion gaps are at the upper limit of treatability in this patient group using current tTEER devices.Dr Fedrico de Marco (Centro Cardiologico Monzino IRCCS, Milan, IT) joins us to discuss the management and outcomes from the FATE registry, which investigated 123 case of failed tricuspid transcatheter edge-to-edge repair (tTEER) with all… View more

Intervention
ESC 2025 Hot Line & Late-Breaking Collection
Author(s): Joost Daemen , Nicolas M Van Mieghem Added: 5 months ago
Dive into our coverage of ESC Congress 2025 for groundbreaking trial results and discussions with expert faculty.Watch ourView From the Thoraxcenterseries for practice-focused reviews of the most anticipated trials from interventional experts,Prof Nicolas Van MieghemandDr Joost Daemen. Watch our Wrap-Upseries led byDr Mirvat Alasnag summarising the key take-aways from each day of the congress.For… View more

Cardiovascular Surgery

CV Disease in Special Populations
TCT 25: Real-World EVOQUE Outcomes from TVT Registry
Author(s): Raj Makkar Added: 2 months ago
TCT 25 - Dr Raj Makkar (Cedars-Sinai Medical Center, US) joins us to discuss the findings on the EVOQUE Valve (Edwards Lifesciences) drawing from data in the STS/ACC Transcatheter Valve Therapy Registry.The study evaluated procedural success rates, in-hospital complications, and 30-day clinical outcomes in patients undergoing transcatheter tricuspid valve replacement for severe tricuspid… View more

Intervention